RE: RNS out15 Mar 2024 12:10
Personally when you look at the past and potential future of Amapa it's very easy to be optimistic especially if producing a 67% concentrate, huge upside imo.
5.3m x $140/t On a 15 year life NPV10 gets me to circa $1.9bn and on a 25 year life closer to $2.3bn. We own circa 35% of that, even if the equity financing dilutes us to 15% then 15% of $1.9bn is $285m and you're getting that for £8.8m ($11m) market cap so fair to say a significant upside potential, I'll take my chances here personally.